Sophia Genetics SA (SOPH) CHF0.05

Sell:$4.28Buy:$4.36$0.10 (2.36%)

NASDAQ:0.66%
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.28
Buy:$4.36
Change:$0.10 (2.36%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$4.28
Buy:$4.36
Change:$0.10 (2.36%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.

Key people

Ross J Muken
President
Jurgi Camblong
Chief Executive Officer, Co-Founder, Director
George A. Cardoza
Chief Financial Officer
Manuela Da Silva Valente
Chief People Officer
Zhenyu Xu
Chief Scientific Officer
Daan Van Well
Chief Legal and Compliance Officer
Philippe Menu
Chief Medical Officer and Chief Product Officer
Troy M. Cox
Non-Executive Independent Chairman of the Board
Tomer Berkovitz
Non-Executive Independent Director
Jean-Michel Cossiery
Non-Executive Independent Director
Kathy Hibbs
Non-Executive Independent Director
Didier Hirsch
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    SOPH
  • Location
    Switzerland
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    CH1125843347
  • Market cap
    $285.86m
  • Employees
    423
  • Shares in issue
    79.32m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.